ITMCTR2000003620尚未招募4 期
A double-blind, randomized, controlled, multicenter clinical study of Jinhong Decoction in the treatment of sepsis based on the innovative strategy of
onghua Hospital Affiliated to Shanghai University of traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 80（—）
- 性别
- All
入选标准
- •1. The age of onset was between 18 and 80 years old;
- •2. The diagnostic criteria of 2016 international guidelines for severe sepsis and septic shock were met;
- •3. APACHE II score < 30;
- •4. They voluntarily participated in the experiment and signed the informed consent.
排除标准
- •1. Patients with allergy to traditional Chinese medicine and allergic constitution;
- •2. Patients with malignant tumor, liver cirrhosis, chronic renal failure (uremic stage), hematological diseases, HIV and other serious basic diseases were complicated;
- •3. Long term use of hormone, immunosuppressant and other drug treatment of patients;
- •4. Those who suffered from serious mental illness or were unable to cooperate with the trial;
- •5. Those who have participated in other clinical trials at the same time or within 30 days;
- •6. Pregnant and lactating women.
研究者
相似试验
尚未招募
4 期
A randomized, double-blind, controlled, multicenter prospective clinical trial of Huoxiang Zhengqi Oral Liquid to prevent chemotherapy-induced nausea and vomiting following platinum-containing multi-day chemotherapytumorITMCTR2000004069West China Hospital, Sichuan University
撤回
2 期
A controlled, randomised, double-blind, multicenter study, comparing methotrexate vs placebo in steroid-refractory ulcerative colitisCrohns DiseaseM. Crohn10017969NL-OMON32416Besancon University Hospital4
尚未招募
不适用
A Randomized, Controlled, Double-blind, Multicenter Clinical Study of the Electroacupuncture Treatment on Muscle and Bone Balance of Knee OsteoarthritisKnee OsteoarthritisITMCTR2000003638Shanghai Longhua Hospital
尚未招募
3 期
A study evaluating the effect of Filgotinib dose de-escalation in patients with ulcerative colitis in remissioCTRI/2023/05/052646Galapagos NV
进行中（未招募）
1 期
A study evaluating the effect of filgotinib dose de-escalation in patients with ulcerative colitis in remissiolcerative colitis (UC)MedDRA version: 20.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 100000004856EUCTR2022-000719-30-ITGALAPAGOS NV80